A downregulation in CASP5 mRNA expression was observed in the lesional skin of psoriasis patients treated with a TNF inhibitor compared to their skin lesions before the start of the respective therapy (152), indicating a prevention of TNF-induced inflammasome priming. This evidence concerns the gene CASP5 and psoriasis.